News
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...
Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...
New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
8d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...
European Patent Office largely dismisses opposition filed by BioNTech SE, Pfizer Inc., and others in December 2023 ...
Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...
Misinformation about ivermectin took hold during the Covid-19 pandemic and continues to circulate despite medical experts ...
Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai ...
HT-KIT is engineered to selectively bind to mutant KIT mRNA transcripts and block their translation, thereby preventing the production of the KIT protein, a critical driver of tumor growth in cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results